Bio Protocol has launched OpenLabs, a decentralized science (DeSci) product positioned as a coordination layer linking scientific ideas with funding and execution, enabling humans and AI agents to collaborate on research in one platform. According to Foresight News, researchers can post hypotheses or discussion threads that may be upgraded into formal projects after community voting.
Once a project is created, it includes collaboration spaces, bounty tasks, and AI agent support. Bio Protocol said mature projects can seek funding through the Bio Protocol launchpad.
OpenLabs uses a USDC yield-based funding mechanism. Users can stake USDC and choose which projects to support, with funds deposited into audited yield vaults such as Morpho and Aave. The principal is intended to remain unaffected, while only the yield is directed to projects to cover costs including AI agent inference and tool-calling compute expenses.
OpenLabs is now live, and an initial batch of projects is already displayed on the platform.
Bio Protocol Launches OpenLabs to Coordinate Research Projects and USDC Yield Funding
2026-07-03 14:43:40
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
世界杯 | 加拿大科内重伤缺阵数月Next article：
股票市场 | 加拿大股市因新管道提案普涨
